W. F. Benedict

2.4k total citations · 1 hit paper
11 papers, 1.9k citations indexed

About

W. F. Benedict is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, W. F. Benedict has authored 11 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Hematology. Recurrent topics in W. F. Benedict's work include Cancer-related Molecular Pathways (5 papers), Acute Myeloid Leukemia Research (4 papers) and Ocular Oncology and Treatments (3 papers). W. F. Benedict is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Acute Myeloid Leukemia Research (4 papers) and Ocular Oncology and Treatments (3 papers). W. F. Benedict collaborates with scholars based in United States, Spain and Canada. W. F. Benedict's co-authors include A. Linn Murphree, Louise C. Strong, Webster K. Cavenee, Brenda L. Gallie, Robert A. Phillips, Thaddeus P. Dryja, R. White, Roseline Godbout, Dennis C. Quinlan and Hang Xu and has published in prestigious journals such as Nature, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

W. F. Benedict

11 papers receiving 1.8k citations

Hit Papers

Expression of recessive a... 1983 2026 1997 2011 1983 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. F. Benedict United States 9 998 828 443 417 416 11 1.9k
Peter Scully United States 7 1.1k 1.1× 1.4k 1.6× 266 0.6× 587 1.4× 443 1.1× 8 2.0k
Alex Koufos United States 9 1.4k 1.4× 638 0.8× 405 0.9× 260 0.6× 601 1.4× 9 2.3k
M Wada United States 14 882 0.9× 904 1.1× 364 0.8× 127 0.3× 235 0.6× 19 1.6k
Rosalyn Slater Netherlands 28 1.4k 1.4× 478 0.6× 392 0.9× 151 0.4× 493 1.2× 69 2.4k
M B Valentine United States 12 904 0.9× 563 0.7× 189 0.4× 69 0.2× 249 0.6× 13 1.4k
Jane Weaver-Feldhaus United States 10 1.9k 1.9× 1.8k 2.2× 757 1.7× 81 0.2× 294 0.7× 10 3.1k
Nadem Soufir France 22 877 0.9× 649 0.8× 323 0.7× 93 0.2× 191 0.5× 47 1.7k
Nicolas Janin France 19 818 0.8× 620 0.7× 314 0.7× 116 0.3× 358 0.9× 40 1.5k
Amy Coxon United States 16 851 0.9× 1.0k 1.3× 199 0.4× 152 0.4× 75 0.2× 20 1.6k
J Kassel United States 7 2.2k 2.2× 2.6k 3.2× 955 2.2× 75 0.2× 777 1.9× 7 3.8k

Countries citing papers authored by W. F. Benedict

Since Specialization
Citations

This map shows the geographic impact of W. F. Benedict's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. F. Benedict with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. F. Benedict more than expected).

Fields of papers citing papers by W. F. Benedict

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. F. Benedict. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. F. Benedict. The network helps show where W. F. Benedict may publish in the future.

Co-authorship network of co-authors of W. F. Benedict

This figure shows the co-authorship network connecting the top 25 collaborators of W. F. Benedict. A scholar is included among the top collaborators of W. F. Benedict based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. F. Benedict. W. F. Benedict is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Benedict, W. F., et al.. (1996). Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1. Blood. 88(1). 268–276. 46 indexed citations
2.
Benedict, W. F., et al.. (1996). Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1. Blood. 88(1). 268–276. 8 indexed citations
3.
Zhang, W, M Beran, TL Smith, et al.. (1994). Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood. 84(1). 256–261. 60 indexed citations
4.
Xu, Hang, Dennis C. Quinlan, A.G. Davidson, et al.. (1994). Altered Retinoblastoma Protein Expression and Prognosis in Early-Stage Non-Small-Cell Lung Carcinoma. JNCI Journal of the National Cancer Institute. 86(9). 695–699. 108 indexed citations
5.
Zhang, W, M Beran, TL Smith, et al.. (1994). Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood. 84(1). 256–261. 3 indexed citations
6.
Benedict, W. F., et al.. (1987). Complete or partial homozygosity of chromosome 13 in primary retinoblastoma.. PubMed. 47(15). 4189–91. 46 indexed citations
7.
Cavenee, Webster K., Thaddeus P. Dryja, Robert A. Phillips, et al.. (1983). Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 305(5937). 779–784. 1555 indexed citations breakdown →
10.
Porter, Ian, et al.. (1973). Giemsa banding in an established line of a human malignant meningioma. Human Genetics. 18(2). 185–187. 12 indexed citations
11.
Benedict, W. F. & Ian Porter. (1972). The cytogenetic diagnosis of malignancy in effusions.. PubMed. 16(4). 304–6. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026